JPMorgan Chase & Co. 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-09 1:40 pm Sale |
2024-07-31 | 13G | Twist Bioscience Corporation TWST |
J P MORGAN CHASE & CO JPM |
2,509,417 4.300% |
-1,953,077 (-43.77%) |
Filing |
| 2024-01-25 11:11 am Unchanged |
2023-12-29 | 13G | Twist Bioscience Corporation TWST |
J P MORGAN CHASE & CO JPM |
4,462,494 7.700% |
0 (Unchanged) |
Filing |
| 2024-01-25 11:10 am Purchase |
2023-12-29 | 13G | Twist Bioscience Corporation TWST |
J P MORGAN CHASE & CO JPM |
4,462,494 7.700% |
632,532 (+16.52%) |
Filing |
| 2023-01-13 09:28 am Purchase |
2022-12-30 | 13G | Twist Bioscience Corporation TWST |
J P MORGAN CHASE & CO JPM |
3,829,962 6.700% |
2,049,403 (+115.10%) |
Filing |
| 2021-01-06 12:59 pm Sale |
2020-12-31 | 13G | Twist Bioscience Corporation TWST |
J P MORGAN CHASE & CO JPM |
1,780,559 3.600% |
-792,272 (-30.79%) |
Filing |